期刊文献+

姜黄素协同顺铂对卵巢癌耐药细胞株COC1/DDP抑制作用的实验研究 被引量:7

Inhibitory effects of curcumin coordinated DDP on cisplatin-resistance human ovarian cancer line COC1/DDP
下载PDF
导出
摘要 目的观察姜黄素协同顺铂对卵巢癌耐药细胞株COC1/DDP细胞的抑制作用的影响。方法采用MTT法检测实验组Ⅰ顺铂(1,1.5,2.5、5μg/ml)作用以及实验组Ⅱ顺铂(1,1.5,2.5、5μg/ml)个浓度与姜黄素(20μmol/L)联合作用于COC1/DDP细胞各48h并观察两实验组作用结果。用透射电镜观察姜黄素(25μmol/L)培养24h COC1/DDP细胞的超微结构。结果顺铂浓度在(1-5)μg/ml时加入姜黄素20μmol/L后,耐药细胞生存率曲线下降明显(P〈0.05),尤以顺铂2.5μg/ml和姜黄素20μmol/L作用时耐药细胞抑制率提高最明显。单用DDP组细胞抑制为31.673±0.125(%),DDP与姜黄素联用组细胞抑制为58.965±0.109(%),两药联用与单独用DDP相比抑制细胞增殖作用显著增强(P〈0.05)。透射电镜观察姜黄素组作用24h后COC1/DDP细胞超微结构,可见细胞表面微绒毛消失,细胞核固缩,染色体凝集成新月状,形成凋亡小体。结论姜黄素可增强COC1/DDP对顺铂的敏感性,这可能与姜黄素和顺铂协同诱导并促进细胞凋亡发生有关。 Objective To investigate the effect and its mechanism of curcumin cooperated with DDP on the apoptosis sensitivity of the COC1/DDP. Methods With MTT(Methyl Thiazolyl Tetrazolium) method to study on the work result of COC1/DDP cells after 48 hours,which been done with Group Ⅰ DDP(1,1.5,2.5,5μg/ml) and with Group Ⅱ DDP(1,1.5,2.5、5μg/ml) that each concentration DDP combined with curcumin(20μmol/L);Use the transmission electron microscope to observe the the ultramicro-fracture of COC1 DDP cell that after 24 h later influenced by curcumin(20μmol /L). Results 1-5μg/ml DDP combined with 20μmol/L curcumin could decrease surviving rates of COC1/DDP cells(P〈0.05),especially 2.5μg/ml DDP combined with 20μmol/L curcumin;The depressant effection of COC1/DDP cells with DDP combined with curcumin were significantly higher than that of only DDP and curcumin(P〈0.05). 24 hours after the treatment of curcumin(20μmol/L) with COC1/DDP,We observed by transmission electron microscope that microvillus disappeared on the surface of COC1/DDP cells,cell-nucleus was condensed,and the chromosomal was been agglutinated crescent,apoptosis body had been formed. Conclusion curcumin can enhance the sensitivity of DDP to COC1/DDP,mechanism may be associated with the induction and promotion to the apoptosis of COC1/DDP by curcumin coordinated DDP.
出处 《江西医药》 CAS 2016年第11期1165-1167,共3页 Jiangxi Medical Journal
基金 江西省卫生计生委中医药科研课题:2015A101
关键词 卵巢癌 姜黄素 顺铂 耐药 细胞凋亡 Ovarian cancer Curcumin DDP Drug resistance Cell apoptosis
  • 相关文献

参考文献4

二级参考文献51

  • 1佟丽,孟庆棣,陈育尧,许俊杰.姜黄素对血小板聚集及血液粘度的影响[J].第一军医大学学报,1990,10(4):364-366. 被引量:9
  • 2李慧,任素蓉,廖东彪,周筱秋,杜小波.腹腔和静脉双途径应用紫杉醇加顺铂治疗晚期卵巢癌的临床观察[J].重庆医学,2007,36(12):1177-1178. 被引量:13
  • 3薛春生.姜黄素抗运动粥样硬化作用的初步实验研究[J].新医药杂志,1978,(9):59-59.
  • 4李洪君,刘丽影.复发性卵巢癌的诊治现状[J].临床肿瘤学杂志,2007,12(7):553-556. 被引量:16
  • 5Recchia F, Saggio G, Amiconi G, et al. A multicenter phase Ⅱ study of pegylated liposomal Doxorubicin and Oxaliplatin in recurrent ovarian cancer. Gyneeol 0ncol,2007,106(1) : 164.
  • 6Pectasides D, Pectasides M, Farmakis D, et al. Oxaliplatin plus high - dose leucovorin and 5- fluorou racil ( FOLFOX 4) in platinum - resistant and taxanepretreated ovarian cancer: a phase Ⅱ study. Gynecol Oncol,2004,95(1):165.
  • 7Vander Burg M E, de Wit R, Van Putten W L, et al . Weekly cisplat in and daily oral etoposide is highly effective in platinum pretreated ovarian cancer. Br J Cancer, 2002, 86(1) : 19.
  • 8Meyer T, Nelstrop A E , Mahmoudi M, et al. Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer . Ann Oncol, 2001, 12(12) : 1705.
  • 9Johnston SR, Gore ME. Caelyx: phase II studies in ovarian cancer . Eur J Cancer ,2001,37(Suppl 9):s8.
  • 10Gordon AN, Fleagle JT, Guthrie D.Recurrent epithelial ovarian carcinoma :a randomized phase III study of pegylated liposomal doxorubiein versus topotecan .J Clin Oncol ,2001,19(14):3312.

共引文献79

同被引文献62

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部